Latest Articles Page 164 of 359
-
Short Communication February 28, 2023
P.1-2
J Cancer Immunol Ther: 6(1): 1-2
Advanced surgical technologies and perspectives of cancer treatment
Author(s): Bowen Lin
-
Case Report February 04, 2023
P.1-2
J Cancer Immunol Ther: 6(1): 1-2
Development and risk prediction factor for breast cancer
Author(s): Tengyang li
-
Perspective February 06, 2023
P.1-2
J Cancer Immunol Ther: 6(1): 1-2
Articulation, managing component and helpful objective of KIF20A in various diseases.
Author(s): Liam Xing
-
Mini Review February 28, 2023
P.1-2
J Cancer Immunol Ther: 6(1): 1-2
Metabolic exchanges between B cells and anticancer invulnerability
Author(s): Jia lian
-
Short Communication February 28, 2023
P.1-2
J Cell Biol Metab: 5(1): 1-2
Foundational cells microorganisms: past, present, and future.
Author(s): Leaoni Ric*
-
Perspective February 28, 2023
P.1-2
J Cell Biol Metab: 5(1): 1-2
A brief note on Mesenchymal stem cells.
Author(s): Liean Yei*
-
Mini Review February 28, 2023
P.1-2
J Cell Biol Metab: 5(1): 1-2
Instigated Pluripotent Undifferentiated cells and Their True capacity for Essential and Clinical Sciences.
Author(s): Masato Nakagawa*
-
Commentary February 28, 2023
P.1-2
J Cell Biol Metab: 5(1): 1-2
Undifferentiated cell based Items in Medication: FDA Regulatory Considerations.
Author(s): Plave Tyi*
-
Brief Report February 28, 2023
P.1-2
J Cell Biol Metab: 5(1): 1-2
Genomics and proteomics in undifferentiated organism.
Author(s): Keyeli Manti*
-
Rapid Communication February 28, 2023
P.1-2
Fundamental components of signal transduction pathways involved in neurotransmission.
Author(s):